You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Automatic Dependent Surveillance- Broadcast (ADS-B) and UAS operations

    SBC: KALSCOTT ENGINEERING INC.            Topic: AF171045

    The USAF has identified the need for ADS-B systems for UAVs. Details of Phase 1 work are discusssed. Methods to enhance ADS-B functionality which were identified and investigated in Phase I are presented. A detailed Phase II work plan consisting of software design, simulations, hardware development and flight testing is presented.

    SBIR Phase II 2019 Department of DefenseAir Force
  2. Advanced Combat Simulation for More Effective Anti-Terrorist Operations

    SBC: DECISIVE POINT LLC            Topic: AF07T023

    Ongoing anti-terrorist and counter-insurgency operations in Iraq following the lightning conventional war of spring 2003 highlight the fact that war is seldom as simple or as quickly resolved as we expect-or hope-it to be. Even more importantly, they remind us that no enemy is truly beaten unless and until they accept that they are. Although the U.S. military succeeded in an impressively rapid and ...

    STTR Phase I 2008 Department of DefenseAir Force
  3. Ultra-low-power analog seizure detection algorithm

    SBC: FLINT HILLS SCIENTIFIC, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Development of implantable devices for automated detection, quantification, warning and delivery of therapy to block seizures is a very important unmet medical need. Making such a device as small as possible, minimizin g replacement surgeries, and maximizing device longevity and/or time between battery recharging are some of the most important development driv ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Virtual Sensor Wiring Harness for Hazardous Environments

    SBC: KALSCOTT ENGINEERING INC.            Topic: A07020

    Continuous environmental health monitoring is a growing requirement for missile systems to ensure their long-term reliability while being stored, transported and operated in harsh environmental conditions. While several sensors currently exist for measuring temperature, relative humidity, shock/vibration, and other key parameters, the wiring required for such a network of embedded sensors, special ...

    SBIR Phase I 2008 Department of DefenseArmy
  5. Wi-Fi From the Sea

    SBC: KALSCOTT ENGINEERING INC.            Topic: N06092

    The challenge to deploying ship-based Wi Fi capability lies in developing the demanding RF and signal processing technology necessary to establish a 25nm ship-to-shore / ship-to-ship link in the presence of shipboard interference. Several new technologies are proposed to address this challenge. The Phase II effort will culminate in a live, real-environment test.

    SBIR Phase II 2008 Department of DefenseNavy
  6. Nanocrystalline Materials for Removal of Reduced Sulfur and Nitrogen Compounds from Fuel Gas

    SBC: NanoScale Materials, Inc.            Topic: N/A

    Integrated gasification combined cycle (IGCC), which uses a gasilier to convert coal to fuel gas, and then uses a combined cycle power block to generate electricity. is one of the most promising technologies for generating electricity from coal in an environmentally sustainable way. IGCC has many advantages over traditional technologies including: higher efficiency, lower pollutant emissions, and ...

    SBIR Phase II 2008 Environmental Protection Agency
  7. Engineered Reactive Metal Oxyhydroxides (ERMO) for Detection and Decontamination of Toxic Reagents

    SBC: NanoScale Materials, Inc.            Topic: A08T016

    Several shortcomings such as lack of reactivity and selectivity are associated with currently available sorbent-based decontaminants. For example, carbon based sorbents can only physisorb toxins without neutralizing them. Secondly, all solid sorbents are sensitive to humid air. Thirdly, reduced reactivity due to mass transfer problem is characteristic of solid sorbents. Finally, solid sorbents ...

    STTR Phase I 2008 Department of DefenseArmy
  8. From Nanoparticles to Novel Protective Garments

    SBC: NanoScale Materials, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this project is to develop breathable, lightweight and disposable chemical protective clothing for use by personnel associated with law enforcement agencies, emergency medical services, medical/triage facili ties, and other federal, state, or local emergency agencies as well as by fire fighters and civilian first responders. This goal will be accomp ...

    SBIR Phase II 2008 Department of Health and Human ServicesCenters for Disease Control and Prevention
  9. SBIR TOPIC 252- FUNCTIONALIZED BIMAGNETIC CORE/SHELL FE/FE3O4 STEALTH NANOPARTIC

    SBC: NanoScale Materials, Inc.            Topic: N/A

    Early diagnosis and early treatment of cancer greatly improve the likelihood of long-term survival and health. Chemical structures that are selectively taken by cancerous tissue can be used to pull diagnostic and therapeutic moieties to cancerous tissue. Appropriately sized iron and/or iron oxide nanoparticles are effective for both diagnosis (via magnetic resonance imaging, MRI) and therapy (by h ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Anabolic Therapeutics for Increasing Bone Denisty and Quality

    SBC: OsteoGeneX Inc            Topic: N/A

    DESCRIPTION (provided by applicant): OsteoGeneX is developing a therapeutic directed against the new bone target Sclerostin (SOST) for the treatment of osteoporosis and related bone disorders. Through genomic approaches Sclerostin was identified as a mast er regulator of bone mass affecting men and women. Using proteomic approaches Dr. Ellies and Krumlauf discovered and patented Sclerostin's mech ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government